Endra Life Sciences closes $4.5M public offering, with full exercise of option
ANN ARBOR–The medical device developer Endra Life Sciences Inc. (Nasdaq: NDRA) announced the closing of its previously announced underwritten public offering of 4,312,500 shares of its common stock and warrants …